Similar articles

• Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.

  Iacopetta B, Watanabe T. Iacopetta B, et al. Gut. 2006 Nov;55(11):1671-2. Gut. 2006. PMID: 17047121 Free PMC article. No abstract available.
• p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy.

  Tang R, Wang JY, Fan CW, Tsao KC, Chen HH, Wu CM, Chen JS, Changchien CR, Hsieh LL. Tang R, et al. Cancer Lett. 2004 Jul 8;210(1):101-9. doi: 10.1016/j.canlet.2004.01.006. Cancer Lett. 2004. PMID: 15172127
• Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

  Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S. Ribic CM, et al. N Engl J Med. 2003 Jul 17;349(3):247-57. doi: 10.1056/NEJMoa022289. N Engl J Med. 2003. PMID: 12867608 Free PMC article. Clinical Trial.
• Biologic behavior of microsatellite-unstable colorectal cancer and treatment with 5-fluorouracil.

  Niv Y. Niv Y. Isr Med Assoc J. 2005 Aug;7(8):520-4. Isr Med Assoc J. 2005. PMID: 16106779 Review.
• Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.

  Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E. Guastadisegni C, et al. Eur J Cancer. 2010 Oct;46(15):2788-98. doi: 10.1016/j.ejca.2010.05.009. Epub 2010 Jun 4. Eur J Cancer. 2010. PMID: 20627535 Review.